Project Grant S10OD038259

Award Date 5/15/25
Completion Date 5/14/26
Dollars Obligated $1.9M
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The University of California, Irvine was awarded a $348,723 Project Grant under the National Institutes of Health's Research Infrastructure Programs (CFDA 93.351) to automate next-generation sequencing and beadarray workflows for their Genomics Research and Technology Hub. The award will fund the acquisition of a Hamilton Liquidscan NGS STAR system to improve the accuracy, reproducibility, and throughput of their genomic analysis capabilities. This workflow modernization aims to support the...
This $454,942 Project Grant awarded by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will enable the University of California, San Diego (UCSD) to acquire a state-of-the-art Cytek Aurora full-spectrum flow cytometer for its Human Embryonic Stem Cell Core Facility. The new instrument will provide researchers across UCSD and four partner institutions access to advanced 40+ parameter multiparametric flow cytometry analysis and high-throughput...
This federal Project Grant award, provided by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351), supports the acquisition and integration of an automated robotic culture system for organoid generation, maintenance, and phenotyping at Emory University's Organoid Hub. The $1,521,607 grant, awarded on May 15, 2025, will enable the university to automate its organoid culture capabilities, enhancing standardization, scalability, and accessibility. This...
This Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) provides $748,908 to the University of California, Santa Cruz (UCSC) to acquire a BD FACSymphony S6 high-parameter cell sorter. This state-of-the-art instrument will replace UCSC's aging cell sorting equipment and enable advanced flow cytometry analysis and cell sorting capabilities to support high-impact, NIH-funded research across the university's physical, biological, and...
This Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) provides $1,574,994 to the University of California, Los Angeles (UCLA) to acquire a state-of-the-art high-resolution tandem mass spectrometer. This specialized instrument will support structural characterization of a broad range of large biological and synthetic molecules across over 11 NIH-funded research projects at the university. The mass spectrometer's capabilities...
The National Institute of General Medical Sciences (NIGMS) awarded a $350,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Dragonase LLC in Minneapolis, MN to develop a fully autonomous robotic wet lab for optimizing hematopoietic stem cell (HSC) culture media. The project, running from June 2025 to February 2026, aims to build a "machine biologist" system consisting of a robotic wet lab and machine learning computer vision models to rapidly and...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $752,359 Project Grant under the National Institutes of Health's Research Infrastructure Programs (CFDA #93.351) to purchase a state-of-the-art Thermo Fisher Scientific Invitrogen Bigfoot Full Spectrum Cell Sorter. This high-throughput, full-spectrum flow cytometer will complement UCSF's existing suite of advanced cell analysis instruments, enabling researchers to simultaneously analyze up to 35-40 parameters on...
This STTR project grant awarded by the National Institute of General Medical Sciences (NIGMS), under CFDA 93.859 Biomedical Research and Research Training program, aims to advance the commercialization of an innovative automated cell culturing system. The $295,038 award to Altvivo, Inc. will enable the development of capabilities that overcome limitations of conventional cell culturing technologies. Key objectives include: 1) achieving complex tissue patterns by inducing different cell...
The National Institutes of Health (NIH) awarded a $713,643 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to The Trustees of Columbia University in the City of New York, Health Sciences Division, for the acquisition of a BD FACSDiscover S8 cell sorter. This state-of-the-art instrument combines high-speed droplet sorting with real-time imaging, full-spectrum detection, and 6-way sorting capabilities. The FACSDiscover S8 will be integrated into Columbia University's...
The National Institutes of Health National Institute of General Medical Sciences awarded New Jersey Institute of Technology a $832,624 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to develop an automated microfluidics technology for minimally disruptive analysis of cells and fluids within living 3D cultures. The three-year project beginning July 1, 2022 aims to design a novel microfluidic plumbing architecture capable of performing thousands of XYZ...

This Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will provide $1,869,146 to the University of California, Los Angeles (UCLA) to purchase the CellXpress.AI Automated Cell Culture System. The new instrument will enable researchers at UCLA to scale cell culture production in support of high-throughput screening campaigns and the development of advanced cellular models like engineered cell lines, organoids, and spheroids. This infrastructure investment aims to meet the growing demand for these research capabilities across UCLA's biomedical, natural sciences, and engineering research programs, which are supported by over $268 million in active federal funding. The automated cell culture system is expected to improve the rigor and repeatability of cell-based research by eliminating human-associated variability and errors. Together with UCLA's existing high-throughput screening facilities and libraries, this new instrument will enhance the university's drug discovery capabilities and support the translation of its academic research discoveries into new drug treatments.

Generated 6/17/25, 3:54 AM